uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 28, 2015

Abnormal Heart Rhythms Linked with Unauthorized Natural Product, Health Canada Warns

On July 27, 2015, Health Canada (the Canadian equivalent of the U.S. FDA) announced that it has received a serious adverse reaction report of abnormal heart rhythms associated with the use of an unauthorized natural product in Canada called Remogen, which contains the drug ibogaine.

Ibogaine is psychoactive substance derived from the root bark of an African shrub, which is sometimes promoted to treat drug addiction. Serious adverse events associated with use of ibogaine have been reported in other countries, including respiratory arrest, cardiac problems such as irregular heartbeat, seizures, symptoms related to psychiatric and metabolic dysfunction and death.

There are no authorized health products containing ibogaine in Canada. However, Health Canada recently seized a number of unauthorized products containing ibogaine which were being sold in Canada under the names Remogen, Ibo + Plus, Endabuse and Iboga by Phytostan Enterprise Inc.

It is not clear whether any of these products were sold in the U.S., where ibogaine is classified as a controlled substance.

See Related Warnings:

Herbal Laxative and "Detox" Kit Containing High Levels of Lead and/or Arsenic Recalled in Canada

Health Canada Suspends Sales of Male Fern

Sexual Enhancement Supplement Recalled

CELLFOOD Recalled in Canada

Canada Advises Consumers Not To Use Adulterated Sleep Supplement

Health Canada Warns Consumers Not to Take Chaparral

To read Health Canada's statement, use the link below.